Sales Support Material
Our testing solution is complementary to existing diagnostic strategies (clinical workup, MRI findings, and other laboratory solutions) and delivers a real-time view of disease activity which providers have never had access to before. IsolateMS presents additional information for the MS specialist, general neurologist, or internal medicine provider to consider as they determine whether or not a patient has clinically definite MS. The test is greater than 90% accurate at the earliest sign of symptoms.
IsolateFibromyalgia® offers providers a new tool to quickly and accurately identify fibromyalgia syndrome. This breakthrough RNA blood test can ‘rule in’ or ‘rule out’ a suspected diagnosis of fibromyalgia and our technology delivers an accuracy rate of 94 percent. The test uses a simple blood draw to analyze RNA patterns found in a patient sample to see if it is consistent with a diagnosis of fibromyalgia syndrome.
IsolateIBS-IBD® offers providers an accurate new tool to identify Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD) at the earliest onset of symptoms, and more importantly, to distinguish among IBS, Crohn’s and ulcerative colitis. The test uses a simple blood draw and delivers accuracy greater than 90%.